Mylan – Recall of nizatidine
January 8, 2020 - Mylan announced a voluntary, consumer-level recall of nizatidine capsules due to detected trace amounts of N-nitrosodimethylamine (NDMA) contained in the active pharmaceutical ingredient (API), manufactured by Solara Active Pharma Sciences Limited.
Download PDF
